Ironwood Pharma Inc Class A (IRWD) returns
Ironwood Pharma returns over 10 years
$1,000 invested in Ironwood Pharma ten years ago was worth $265.35 at the close on October 30, 2026, with dividends reinvested: an average return of -12.4% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -11.8% | — | $881.61 | -0.9% |
| 3 months | -6.2% | — | $938.34 | +2.1% |
| Year to date | +3.9% | — | $1,039 | +11.7% |
| 1 year | +133.3% | — | $2,333 | +12.4% |
| 3 years | -60.8% | -26.8% | $391.94 | +88.5% |
| 5 years | -72.6% | -22.8% | $274.08 | +76.0% |
| 10 years | -73.5% | -12.4% | $265.35 | +316.6% |
Ironwood Pharma return by calendar year
| Year | IRWD | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +3.9% | +11.7% | -7.8% |
| 2025 | -23.9% | +17.7% | -41.6% |
| 2024 | -61.3% | +24.9% | -86.2% |
| 2023 | -7.7% | +26.2% | -33.9% |
| 2022 | +6.3% | -18.2% | +24.4% |
| 2021 | +2.4% | +28.7% | -26.4% |
| 2020 | -14.4% | +18.4% | -32.8% |
| 2019 | +28.5% | +31.2% | -2.7% |
| 2018 | -30.9% | -4.6% | -26.3% |
| 2017 | -2.0% | +21.7% | -23.7% |
| 2016 | +31.9% | +12.0% | +19.9% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: IRWD financials · IRWD valuation
No forecast, no recommendation. This page describes Ironwood Pharma Inc Class A from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.